透過您的圖書館登入
IP:18.218.252.32
  • 期刊

Research on Quality Indictor of New Drug Based on Customer Perspective

摘要


The single evaluation indictor of new drug quality hinders the market and customers' cognition of new drug quality, which is not conducive to the rapid launch of new drugs. Based on the market, this research establishes a comprehensive evaluation indictor system of new drug quality from the perspective of customer demand. To improve the quality of new drugs, as soon as possible to provide scientific basis for the market.

參考文獻


Cronbach, LJ (1951).Coefficient alpha and the internal structure of tests. Psychometrika. 16, 297-334.
Glaser, B. G., & Strauss, A. L. (1967). The discovery of grounded theory: Strategies for qualitative research. Chicago, IL: Aldine Transaction.
Mai Wang. (2017). Clinical trials and drug approvals continue to accelerate in China. THE LANCET JOURNALS .18(7,) P:855.
Mehul U. Mehta. (2017). Impact of the US FDA “Biopharmaceutics Classification System”(BCS) Guidance on Global Drug Development. Mol. Pharmaceutics ,14,(12),P: 4334-4338.
CFDA. (2017). Administrative measures for drug registration. http://samr.cfda.gov.cn:2007.10.01.

延伸閱讀